[1] Li J,Liu L,Song LX,et al.Clinical Features and Outcomes of Pulmonary Artery Sarcoma. Heart Lung Circ,2022,31(2):230-238.
[2] Song W,Deng L,Zhu J,et al.Surgical treatment of pulmonary artery sarcoma:a report of 17 cases. Pulm Circ,2021,11(1):2045894020986394.
[3] Linch M,Miah AB,Thway K,et al.Systemic treatment of soft-tissue sarcoma-gold standard and novel therapies. Nat Rev Clin Oncol,2014,11(4):187-202.
[4] Uchida A,Tabata M,Kiura K,et al.Successful treatment of pulmonary artery sarcoma by a two-drug combination chemotherapy consisting of ifosfamide and epirubicin. Jpn J Clin Oncol,2005,35(7):417-419.
[5] Chen X,Ren S,Li A,et al.A case report of chemo-sensitive intimal pulmonary artery sarcoma. Cell Biochem Biophys,2014,68(1):153-157.
[6] Noguchi T,Gomi D,Fukushima T,et al.A Case of Unresectable Pulmonary Artery Intimal Sarcoma with Prolonged Survival by Chemotherapy. Case Rep Oncol,2019,12(1):192-198.
[7] Xu Y,Wang K,Geng Y,et al.A case of intimal sarcoma of the pulmonary artery successfully treated with chemotherapy. Int J Clin Oncol,2012,17(5):522-527.
[8] Siozopoulou V,Domen A,Zwaenepoel K,et al.Immune Checkpoint Inhibitory Therapy in Sarcomas:Is There Light at the End of the Tunnel?. Cancers (Basel),2021,13(2):360.
[9] 张长征,苗秀英. 信迪利单抗联合化疗、重组人血管内皮抑素治疗肺动脉内膜肉瘤1例.临床肿瘤学杂志,2023,28(3):284-286.
[10] Kim C,Kim MY,Kang JW,et al.Pulmonary Artery Intimal Sarcoma versus Pulmonary Artery Thromboembolism:CT and Clinical Findings. Korean J Radiol,2018,19(4):792-802.
[11] 弓莉,杨瑞,刘继伟,等. 肺动脉肉瘤与肺栓塞临床及影像学特征对比. 河南医学研究,2023,32(19):3585-3588.
[12] Xi XY,Gao W,Gong JN,et al.Value of 18F-FDG PET/CT in differentiating malignancy of pulmonary artery from pulmonary thromboembolism:a cohort study and literature review. Int J Cardiovasc Imaging,2019,35(7):1395-1403.
[13] Atahan C,Güral Z,Yücel S,et al.Pulmonary artery intimal sarcoma:Case report of a patient managed with multimodality treatment and a comprehensive literature review. Strahlenther Onkol,2024,200(8):725-729. |
京公网安备11010202007215号
Total visitors: Visitors of today: Now online:
This work is licensed under Creative Commons Attribution 3.0 License.
